Free shipping over $200.00Free 5 mL bacteriostatic water over $200.00

Longevity

PT-141 (Bremelanotide) 10 mg

$59.00$99.0099.5% purity · Batch PT-260820

Melanocortin receptor agonist heptapeptide studied in neuroendocrine and behavioural research models.

Lot analysis published for this batch. Independent Janoshik Analytical testing (Sep 2026) — purity, content and endotoxin, shown unedited further down this page.
1
  • Third-party HPLC & mass-spec verified
  • Same-day dispatch before 2 PM ET
  • Cold-packed, tamper-sealed shipping
  • Batch-coded and dated at fill

Research background

PT-141 (bremelanotide) is a cyclic heptapeptide analogue of alpha-MSH investigated in melanocortin receptor (MC3R/MC4R) signalling research. Supplied lyophilised in a sealed, lot-coded vial; the published lot report lists measured content, purity and endotoxin for this batch.

Research use only. This product is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, food or cosmetic and must not be administered to humans or animals.

Lot analysis for this batch

Lot
PT-260820
Purity (3 vials)
99.54 / 99.65 / 99.56 %
Content (3 vials)
11.24 / 10.96 / 11.33 mg
Endotoxin
2.763 EU/vial
Tested by
Janoshik Analytical, Sep 2026

Published in full and unedited — verify it with the key printed on the report.

Specifications

Molecular formula
C50H68N14O10
Molar mass
1025.2 g/mol
Form
Lyophilised white powder
Storage
-20 °C, protect from light
Certificate of analysis
View batch PT-260820

More in Longevity

LongevityNAD+ 500 mg research vialNAD+ 500 mg certificate of analysis

NAD+ · 500 mg

Nicotinamide adenine dinucleotide reference material for cellular metabolism research.

 

$79.00$129.00
LongevityNewMOTS-c 10 mg research vialMOTS-c 10 mg certificate of analysis

MOTS-c · 10 mg

Mitochondrial-derived 16-amino-acid peptide studied in metabolic homeostasis and exercise-mimetic research.

 

$90.00$149.00

PT-141 (Bremelanotide) 10 mg

$59.00